Latest Healthcare News

Eureka Group Holdings has acquired Townsville Lakes Holiday Park, adding 110 sites and targeting an 18.2% IRR through conversion to long-term rentals amid tight regional housing markets.

Doctor Care Anywhere delivered a 27% rise in EBITDA and doubled free cash flow in H1 2026, driven by operational efficiencies and a strategic entry into the UK weight management market via acquisition.

OncoSil Medical has won FDA Humanitarian Device Exemption approval for its OncoSil™ device to treat distal cholangiocarcinoma, opening a US market estimated at A$80 million annually.

GWA Group posted modest revenue and earnings growth in FY26, driven by volume gains across Australia, New Zealand, and the UK, while raising dividends and advancing strategic priorities despite challenging market conditions.

Marlin Global delivered a robust 3.1% gross portfolio return in July 2026, significantly outpacing its benchmark which fell 3.6%, thanks to strategic semiconductor underweighting and strong gains in tech giants Microsoft, Dexcom, and Amazon.

Barramundi Limited’s portfolio delivered a 2.2% gross return in July, outpacing the S&P/ASX200 hedged benchmark, driven by strong performances in healthcare and financials alongside strategic portfolio adjustments.

Sigma Healthcare will release its FY26 full year results on 27 August, unveiling a new segment reporting structure dividing Australia and International operations. The update aims to clarify performance amid ongoing international growth and merger integration.

L1 Group has partnered with Dr Andrew Lin to launch PXC Advisors, a global long short investment manager boasting a 51% annualised return since 2024. The strategy will open to external investors in September 2026 and take over management of the Platinum International Technology Fund.

ResMed Inc. posted a 10% rise in fiscal 2026 revenue to $5.65 billion, bolstered by the acquisition of Noctrix Health and an agreement to sell its MatrixCare business. The company continues to invest in AI-powered digital health solutions amid ongoing patent litigation and a shifting regulatory landscape.

Green Cross Health CEO Rachael Newfield will step down in January 2027 following the sale of the Medical division, paving the way for a new pharmacy-centric leadership role.

Austco Healthcare has completed the $2.24 million acquisition of Medical Communications Systems, transitioning its long-term South Australian reseller into a direct sales operation to deepen market engagement.

Proteomics International has achieved a key patent acceptance in Australia for its PromarkerEndo blood test, reinforcing its intellectual property portfolio and commercialisation strategy in a major healthcare market.